Business Description
US Stem Cell Inc
NAICS : 325414
SIC : 2836
ISIN : US90350U1007
Compare
Compare
Traded in other countries / regions
USRM.USA IPO Date
2008-02-19Description
US Stem Cell Inc. was a US-based biotechnology company focused on the discovery, development, and commercialization of autologous cell therapies, using a patient's own cells to treat damaged tissue. Its programs targeted chronic and acute heart damage, including its MyoCell therapy, which was designed to repopulate scar tissue in the heart with autologous muscle cells to improve cardiac function in chronic heart failure patients. The company also pursued regenerative treatments for other injuries and diseases. It generated revenue primarily through its subsidiary, the U.S. Stem Cell Clinic, which offered point-of-care adipose-derived stem cell procedures directly to patients, along with related products and services. The company operated mainly in the United States and was publicly traded over the counter. It faced significant regulatory scrutiny from the FDA over its unapproved stem cell treatments and subsequently entered bankruptcy proceedings.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:USRM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
US Stem Cell Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.082 | ||
| EPS (TTM) ($) | -0.005 | ||
| Beta | -301.8829 | ||
| 3-Year Sharpe Ratio | 0.53 | ||
| 3-Year Sortino Ratio | 5 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.000025 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.00001 - 0.0002 | ||
| Shares Outstanding (Mil) | 641.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
US Stem Cell Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
US Stem Cell Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.001:1 Stock Split | 2015-11-04 | 2.90 (+93.33%) |
Show
Entries
US Stem Cell Inc Frequently Asked Questions
What is US Stem Cell Inc(USRM)'s stock price today?
The current price of USRM is $0.00. The 52 week high of USRM is $0.00 and 52 week low is $0.00.
When is next earnings date of US Stem Cell Inc(USRM)?
The next earnings date of US Stem Cell Inc(USRM) is .
Does US Stem Cell Inc(USRM) pay dividends? If so, how much?
US Stem Cell Inc(USRM) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers